The U.S. medical oxygen concentrators market size accounted for USD 351 million in 2024 and is expected to exceed around USD 658.88 million by 2034, growing at a CAGR of 6.5% from 2025 to 2034.
The U.S. medical oxygen concentrator market is growing steadily due to the growing incidence of respiratory disorders like chronic obstructive pulmonary disease (COPD), asthma, and pulmonary fibrosis. The market is expanding significantly due to the aging population and advancements in portable oxygen concentrator technology. Medical oxygen concentrators, with an emphasis on home-based healthcare interventions, are becoming a crucial component of respiratory treatment. The industry is anticipated to experience tremendous growth in the upcoming decade as technological advancements make these devices more portable and efficient.
The rising prevalence of chronic respiratory diseases, including chronic obstructive pulmonary disease, asthma, and obstructive sleep apnoea, is one of the key drivers for the market demand for medical oxygen concentrators. Smoking, air pollution, and occupational exposure are lifestyle and environmental factors contributing to the increased patient base that needs long-term oxygen therapy. Also, the residual impact of COVID-19 has further underscored the significance of oxygen therapy, emphasizing the need for trustworthy oxygen concentrators in hospitals and at home.
| Industry Worth | Details |
| Market Size in 2024 | USD 351 Million |
| Market Size in 2025 | USD 373.82 Million |
| Market Size by 2034 | USD 658.88 Million |
| Market Growth Rate from 2025 to 2034 | CAGR of 6.5% |
The need for home healthcare services is increasing because of the increased popularity of in-home treatment, particularly among elderly and chronic patients. Medical oxygen concentrators, especially portable ones, are becoming a part of home oxygen therapy, offering more convenience and a better quality of life to patients. With these devices available at home, hospitalization and healthcare expenditures are minimized, increasing their use throughout the U.S. medical oxygen concentrator market.
Innovations in oxygen concentrator technology, including the creation of energy-efficient, smart-enabled, and lightweight devices, are propelling market expansion. Attributes such as enhanced battery life, digital feedback, and connectivity with mobile apps enable patients and medical professionals to monitor oxygen levels in real-time. In the U.S. medical oxygen concentrator market, additional research into noise reduction and device miniaturization is also making these devices more comfortable and useful, which is drawing in more customers.
One of the main constraints of the market is the prohibitively expensive price tag for advanced medical oxygen concentrators, especially portable and continuous-flow types. A lot of patients, particularly those without full health insurance coverage, also consider the devices to be too pricey, restraining accessibility. Furthermore, issues with reimbursement and insurance policy differences also affect the affordability of oxygen concentrators, hindering market penetration in lower-income segments.
Artificial intelligence is playing a revolutionary role in maximizing the performance and functionality of medical oxygen concentrators. AI-based monitoring systems allow real-time monitoring of oxygen levels, device efficiency, and patient vitals, enabling early detection of respiratory distress. AI-based predictive analytics also assist healthcare professionals in personalizing oxygen therapy based on patient information, enhancing treatment outcomes. AI is also optimizing manufacturing processes, lowering production costs, and streamlining supply chain operations, further fuelling U.S. medical oxygen concentrator market growth.
Portable oxygen concentrators are experiencing heightened demand as they become more compact and feature-packed for mobility. As ultra-miniature and ultra-durable battery-operated designs emerge from the manufacturing industry, adoption is also predicted to see growth, primarily among active aging individuals and global travelers in need of continuous oxygen therapy. This development is likely to create innovation and patient adherence to oxygen therapy. With the increasing pressure of respiratory illness, government programs and insurance for home oxygen therapy are anticipated to grow. The U.S. medical oxygen concentrator market can be further broadened by increasing the availability of oxygen concentrators through improved funding for underprivileged patients and better reimbursement policies.
Published by Ajit Bansod
Related Reports
